Left Ventricular Assist Devices
Top Cited Papers
- 11 December 2018
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 138 (24), 2841-2851
- https://doi.org/10.1161/circulationaha.118.035566
Abstract
Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage heart failure patients with >22 000 implantations to date. Though originally conceived for bridge-to-transplant indication, significant advancements in medical management as well as technology with arrivals of newer generation devices have improved patient outcomes, leading to increasing use as destination therapy. Despite such improvement, however, the burden of adverse events remains significant and defines the most pressing issue in the current state of ventricular assist device therapy. Eventual use of ventricular assist device technology as a comparable alternative to heart transplantation will ultimately rely on our ability to mitigate these risks. Therefore, this review article provides the narrative surrounding the rapid integration of this technology into the heart failure paradigm, specifically in the context of the most recent data on its outcomes and adverse event profiles. It describes ongoing investigations and general trends that may have significant implications for future improvements in device-related outcomes, as the field continues to grow as the epitome of synergy between advancements in engineering and clinical medicine.This publication has 57 references indexed in Scilit:
- Epidemiology of Heart FailureCirculation Research, 2013
- The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summaryThe Journal of Heart and Lung Transplantation, 2013
- Axial and centrifugal continuous-flow rotary pumps: A translation from pump mechanics to clinical practiceThe Journal of Heart and Lung Transplantation, 2013
- Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantationThe Journal of Heart and Lung Transplantation, 2012
- Cost-Effectiveness Analysis of Continuous-Flow Left Ventricular Assist Devices as Destination TherapyCirculation: Heart Failure, 2012
- Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist deviceThe Journal of Heart and Lung Transplantation, 2011
- Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classificationThe Journal of Heart and Lung Transplantation, 2010
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceThe New England Journal of Medicine, 2009
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationThe New England Journal of Medicine, 2007
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureThe New England Journal of Medicine, 2001